SNT
BMY.RT

Security National Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Security National Trust’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,699
Closed -$2K – 428
2020
Q4 		$2K Hold
2,699
– – ﹤0.01% 401
2020
Q3 		$6K Hold
2,699
– – ﹤0.01% 374
2020
Q2 		$9K Hold
2,699
– – ﹤0.01% 358
2020
Q1 		$10K Hold
2,699
– – ﹤0.01% 364
2019
Q4 		$9K Buy
+2,699
New +$7.02K ﹤0.01% 383

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Security National Trust's BMY.RT Position: Q1 2021 in Review

Security National Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 2,699 shares — an estimated $2K sold.

Security National Trust first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $10K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Security National Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Security National Trust sold 2,699 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $2K.
  • Security National Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Security National Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $10K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Security National Trust's 13F filing for Q1 2021, filed 4 May 2021.